Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term randomized controlled-trial. Found 25 abstracts

no pagination
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Kelly Marcom P, Mayer IA, McCormick B, Moran MS, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. NCCN Guidelines Insights: Breast Cancer, Version 1.2017. J Natl Compr Canc Netw. 2017 Apr;15(4):433-51.
Packel L, Fang CY, Handorf E, Rodoletz M. A 12-Week Exercise and Stress Management Pilot Program From Theory Through Implementation and Assessment. Rehabilitation Oncology. 2017 Oct;35(4):172-80.
Shaikh T, Meyer JE, Horwitz EM. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Surg Oncol Clin N Am. 2017 Jul;26(3):405-29.   PMCID: REVIEW
Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB, Macdonald JS, Rich TA, Willett CG. FAILURE TO ADHERE TO PROTOCOL SPECIFIED RADIATION THERAPY GUIDELINES WAS ASSOCIATED WITH DECREASED SURVIVAL IN RTOG 9704-A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS. International Journal of Radiation Oncology Biology Physics. 2012 Feb;82(2):809-16.   PMCID: PMC133855
Berger AC, Winter K, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Benson AB, MacDonald J, Willett CG. Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 <= 90 U/mL and Comparison to the CONKO-001 Trial. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(3):E291-E297.
Berger AC, Winter K, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Benson AB, MacDonald J, Willett CG. Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 <= 90 U/mL and Comparison to the CONKO-001 Trial. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(3):E291-E297.
Chen KT. Axilary Disection. Current Problems in Cancer. 2012 Sep;36(5):245-62.
Kim HJ, Barsevick AM, Fang CY, Miaskowski C. Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer Patients. Cancer nursing. 2012 Nov;35(6):E1-E20.   PMCID: not NIH funded
Martins RG, D'Amico TA, Loo BW, Pinder-Schenck M, Borghaei H, Chaft JE, Ganti AK, Kong FM, Kris MG, Lennes IT, Wood DE. The Management of Patients With Stage IIIA Non-Small Cell Lung Cancer With N2 Mediastinal Node Involvement. Journal of the National Comprehensive Cancer Network. 2012 May;10(5):599-613.   PMCID: not NIH funded
Pahlajani N, Ruth KJ, Buyyounouski MK, Chen DY, Horwitz EM, Hanks GE, Price RA, Pollack A. RADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON SCORE 8 TO 10 PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Apr;82(5):1949-56.   PMCID: PMC3827957
Zhang DQ, Fang P, Jiang XH, Nelson J, Moore JK, Kruger WD, Berretta RM, Houser SR, Yang XF, Wang H. Severe Hyperhomocysteinemia Promotes Bone Marrow-Derived and Resident Inflammatory Monocyte Differentiation and Atherosclerosis in LDLr/CBS-Deficient Mice. Circulation research. 2012 Jun;111(1):37-49.   PMCID: PMC3412115
Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C, Huff CA, Kassim A, Medeiros BC, Meredith R, Raje N, Schriber J, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Tricot G, Weber DM, Yahalom J, Yunus F. Multiple Myeloma. Journal of the National Comprehensive Cancer Network. 2011 Oct;9(10):1146-83.   PMCID: not NIH funded
Carlson RW, Allred C, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R. Invasive Breast Cancer. Journal of the National Comprehensive Cancer Network. 2011 Feb;9(2):136-222.   PMCID: not NIH funded - practice guideline
Chun YS, Cooper HS, Cohen SJ, Konski A, Burtness B, Denlinger CS, Astsaturov I, Hall MJ, Hoffman JP. Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer. Annals of Surgical Oncology. 2011 Dec;18(13):3601-7.   PMCID: not NIH funded
Hall MJ, Manne SL, Winkel G, Chung DS, Weinberg DS, Meropol NJ. Effects of a Decision Support Intervention on Decisional Conflict Associated with Microsatellite Instability Testing. Cancer Epidemiology Biomarkers & Prevention. 2011 Feb;20(2):249-54.   PMCID: PMC3076798
Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Rich TA, Willett CG. Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the US Intergroup/RTOG 9704 Phase III Trial. Annals of Surgical Oncology. 2011 May;18(5):1319-26.   PMCID: NIHMS323431 [approved 10-18-12]
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI. Cancer-Related Fatigue. Journal of the National Comprehensive Cancer Network. 2010 Aug;8(8):904-31.   PMCID: not NIH funded
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, MacDonald DJ, Mahoney MC, Merajver SD, Meszoely I, Newman L, Pritchard E, Seewaldt V, Sellin RV, Shapiro CL, Ward JH. Breast Cancer Risk Reduction. Journal of the National Comprehensive Cancer Network. 2010 Oct;8(10):1112-46.   PMCID: not NIH funded
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Som G, Topham NS, Ward JH, Winer EP, Wolff AC. Breast Cancer: Noninvasive and Special Situations. Journal of the National Comprehensive Cancer Network. 2010 Oct;8(10):1182-207.   PMCID: not NIH funded
Dorgan JF, Liu L, Klifa C, Hylton N, Shepherd JA, Stanczyk FZ, Snetselaar LG, Van Horn L, Stevens VJ, Robson A, Kwiterovich PO, Lasser NL, Himes JH, Gabriel KP, Kriska A, Ruder EH, Fang CY, Barton BA. Adolescent Diet and Subsequent Serum Hormones, Breast Density, and Bone Mineral Density in Young Women: Results of the Dietary Intervention Study in Children Follow-up Study. Cancer Epidemiology Biomarkers & Prevention. 2010 Jun;19(6):1545-56.   PMCID: PMCID: PMC2883023 [Available on 2010/12/1]
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term randomized controlled-trial

randomized controlled-trial chemotherapy NCCN Clinical Practice Guidelines NCCN Guidelines quality-of-life surgical adjuvant breast survival radiotherapy curative resection chemoradiation phase-iii trial breast-cancer breast cancer breast-conserving therapy ca-19-9 endocrine therapy radiation therapy first-line therapy intensity-modulated radiotherapy therapy radiation lobular carcinoma in situ resectable pancreatic-cancer serum positron-emission-tomography radiation-therapy cancer placebo-controlled trial mastectomy carcinoma adenocarcinoma tamoxifen gemcitabine carcinoma-in-situ adjuvant chemotherapy lymph-node dissection corticotropin-releasing hormone 6-minute walk test squamous-cell carcinoma 1993 rousos ga-jama-journal of the american medical association-v269-p2110 donor lymphocyte infusions LCIS bone marrow transplantation prevention long-term survival bone-marrow transplantation risk reduction concurrent chemotherapy quality of life combination dietary modification trial phase-ii clinical-trial homocysteine chemoradiotherapy Radiation cytogenetics low-fat BCRA1 emission-tomography Quality assurance rates esophageal cancer stem-cell transplantation united-states breast carcinoma receiving adjuvant chemotherapy thalidomide plus neoadjuvant chemotherapy high-grade dysplasia sentinel node standard axillary treatment colorectal-cancer bisphosphonates high response hospital volume 1993 wler wc-annals of thoracic surgery-v55-p986 consensus statement mindfulness proteasome inhibitor myocardial-infarction cystathionine beta-synthase primary amyloidosis sleep-wake cycle noninvasive breast surgical adjuvant mammographic density rectal-cancer l-carnitine supplementation susceptibility experience treatment prophylactic mastectomy pagets-disease trimodality postoperative radiotherapy neoadjuvant therapy competing risk model pegylated liposomal doxorubicin dexamethasone Chemoradiotherapy critical-appraisal pancreaticoduodenectomy risk assessment 2009 carthy pl-blood-v114 surgery stem cell transplant complete axillary dissection early breast-cancer major-depressive-disorder transplantation sentinel-node biopsy individual patient data stem-cell defining biochemical failure C-reactive protein bilateral prophylactic mastectomy menopausal atherosclerosis inflammatory monocyte-hyperhomocysteinemia comparing 1991 freitas r-european journal of surgical oncology-v17-p240 screening survivorship raloxifene 1987 war ja-international journal of radiation oncology biology physics-v13-p475 High grade Waldenstrom's monoclonal protein postmenopausal women cancer risk saturated fat functional assessment skin-sparing mastectomy induced sickness behavior induction chemotherapy radical-mastectomy american-joint-committee growth-factor receptor reducing salpingo-oophorectomy accelerates 1992 llenius m-sleep-v15-p21 lumpectomy plus tamoxifen tumors novel therapies Radiotherapy conformal radiation-therapy adjuvant therapy physical-activity bone-mineral density clinically localized adenocarcinoma
Last updated on Friday, January 03, 2020